Nukkleus Inc
For the period ended Sep 30, 2024. Filed Feb 10, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NUKKLEUS INC. | ||
| Dated: February 10, 2025 | By: | /s/ Menachem Shalom |
|---|---|---|
| Menachem Shalom | ||
| Chief Executive Officer | ||
| (Principal Executive Officer), and | ||
| Chief Financial Officer | ||
| (Principal Financial and | ||
| Accounting Officer), and Director | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Menachem Shalom | Chief Executive Officer (Principal Executive Officer), Chief Financial | February 10, 2025 |
| Officer (Principal Financial Officer), and Director | ||
| /s/ David Rokach | Chief Operating Officer and Director | February 10, 2025 |
| /s/ Romer Nagar | Director | February 10, 2025 |
| /s/ Aviya Volodarsky | Director | February 10, 2025 |
| /s/ Reuven Yeganeh | Director | February 10, 2025 |
| /s/Anastasiia Kotaieva | Director | February 10, 2025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.